NBF.F NOLATO AB SER.B

Healthcare Industrial Conglomerates Frankfurt Exchange
5.24 EUR
Close of Nov 12, 2026
4.09 5.55
Market cap
EUR 1.27B
P/E
20.4x
P/B
2.34x
ROE
11.7%
Dividend yield
3.38%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is NBF.F undervalued?

Graham number
Price5.24
Graham value3.59
Premium45.7%

NBF.F trades 45.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NOLATO AB SER.B fundamental analysis

No fundamental analysis for NOLATO AB SER.B yet.

NOLATO AB SER.B stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NOLATO AB SER.B

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and dropper bottles. It also provides thermal heating pads, gap fillers, and paste …

Full company profile